Please provide your email address to receive an email when new articles are posted on . “Because there are no permanent adverse reactions or deforming reactions, I think the safety is assured,” Karen ...
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE: AGN) is pleased that the U.S. Food and Drug Administration (FDA) General and Plastic Surgery Devices Panel of the Medical Devices Advisory ...
There's no denying it: plastic surgery is a big commitment. First and foremost, whether the procedure is small or large, it's still making a (most likely) permanent change to your body, which is ...
(RTTNews) - Allergan plc (AGN) said that it received U.S. Food and Drug Administration approval for the use of Juvéderm VOLUMA XC, a hyaluronic acid gel dermal filler, with a TSK STERiGLIDE cannula ...
A US Food and Drug Administration (FDA) panel today unanimously recommended that the agency approve Juvéderm Voluma XC (Allergan) to correct age-related volume deficits in the mid-face. Juvéderm ...
The US Food and Drug Administration (FDA) has approved Juvéderm Voluma XC (Allergan) to correct age-related volume deficits in the midface in adults aged 21 years and older, the company announced ...